Hollow Brook Wealth Management LLC Reduces Holdings in Aflac Incorporated (NYSE:AFL)

Hollow Brook Wealth Management LLC reduced its position in Aflac Incorporated (NYSE:AFL) by 28.2% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 61,031 shares of the financial services provider’s stock after selling 23,957 shares during the period. Aflac comprises approximately 2.0% of Hollow Brook Wealth Management LLC’s holdings, making the stock its 15th biggest holding. Hollow Brook Wealth Management LLC’s holdings in Aflac were worth $5,035,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of AFL. Fortitude Family Office LLC acquired a new position in shares of Aflac in the 4th quarter valued at $25,000. Bruce G. Allen Investments LLC acquired a new position in Aflac in the 4th quarter worth $32,000. Harvest Fund Management Co. Ltd acquired a new position in Aflac in the 3rd quarter worth $33,000. Criterion Capital Advisors LLC acquired a new position in Aflac in the 4th quarter worth $33,000. Finally, Arlington Trust Co LLC acquired a new position in Aflac in the 4th quarter worth $35,000. 67.44% of the stock is owned by hedge funds and other institutional investors.

Aflac Price Performance

AFL stock traded down $0.90 on Tuesday, hitting $83.64. 2,375,264 shares of the company’s stock traded hands, compared to its average volume of 2,271,133. Aflac Incorporated has a 1-year low of $64.10 and a 1-year high of $86.26. The stock has a fifty day moving average of $82.89 and a 200-day moving average of $81.84. The company has a current ratio of 0.06, a quick ratio of 0.06 and a debt-to-equity ratio of 0.33. The stock has a market cap of $48.13 billion, a price-to-earnings ratio of 10.79, a P/E/G ratio of 2.29 and a beta of 0.91.

Aflac (NYSE:AFL) last released its quarterly earnings data on Thursday, February 1st. The financial services provider reported $1.25 earnings per share for the quarter, missing the consensus estimate of $1.47 by ($0.22). The company had revenue of $3.78 billion during the quarter, compared to analyst estimates of $4.44 billion. Aflac had a net margin of 24.92% and a return on equity of 17.59%. During the same quarter in the prior year, the company posted $1.29 EPS. On average, analysts forecast that Aflac Incorporated will post 6.41 EPS for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the stock. StockNews.com downgraded shares of Aflac from a “hold” rating to a “sell” rating in a research report on Wednesday, April 10th. The Goldman Sachs Group upped their target price on shares of Aflac from $61.00 to $75.00 and gave the stock a “sell” rating in a research report on Tuesday, January 9th. Wells Fargo & Company decreased their target price on shares of Aflac from $83.00 to $81.00 and set an “equal weight” rating for the company in a research report on Thursday, April 11th. Morgan Stanley upped their target price on shares of Aflac from $80.00 to $84.00 and gave the stock an “equal weight” rating in a research report on Monday, April 15th. Finally, Evercore ISI cut shares of Aflac from an “in-line” rating to an “underperform” rating and upped their target price for the stock from $76.00 to $78.00 in a research report on Thursday, January 4th. Three analysts have rated the stock with a sell rating, eight have issued a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $82.15.

Insider Buying and Selling at Aflac

In other news, SVP Albert Riggieri sold 8,000 shares of the firm’s stock in a transaction on Thursday, March 14th. The shares were sold at an average price of $83.34, for a total transaction of $666,720.00. Following the transaction, the senior vice president now owns 32,825 shares in the company, valued at approximately $2,735,635.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, Director Arthur Reginald Collins sold 3,000 shares of the firm’s stock in a transaction on Thursday, February 22nd. The shares were sold at an average price of $79.73, for a total value of $239,190.00. Following the transaction, the director now directly owns 5,592 shares in the company, valued at approximately $445,850.16. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Albert Riggieri sold 8,000 shares of the firm’s stock in a transaction on Thursday, March 14th. The shares were sold at an average price of $83.34, for a total transaction of $666,720.00. Following the completion of the transaction, the senior vice president now owns 32,825 shares in the company, valued at $2,735,635.50. The disclosure for this sale can be found here. In the last quarter, insiders have sold 46,493 shares of company stock worth $3,765,706. 0.80% of the stock is currently owned by company insiders.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.